Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Organisation › Details

Lophius Biosciences GmbH

Lophius Biosciences GmbH develops and markets innovative T-cell based testing systems for diagnostics and possible therapy control in the fields of transplantation, infection and autoimmune diseases. *


Period Start 2002-01-01 established
  Predecessor University Hospital Regensburg
Products Industry diagnostics (medical/biological)
  Industry 2 anti-infective drug
Persons Person Wagner, Ralf (Lophius 201301– Managing Director before Geneart AG 1999– founder + CEO + CSO)
  Person 2 Lutz, Michael (HepaRegenix 201910– Managing Director (CEO) before LifeCodexx + Clinical Data/Cogenics + Epidauros)
Region Region Regensburg
  Country Germany
  Street 13 Am BioPark
  City 93053 Regensburg
  Tel +49-941-6309-197-0
    Address record changed: 2017-09-29
Basic data Employees B: 11 to 50 (2017-09-07)
    * Document for �About Section�: Lophius Biosciences GmbH. (1/22/13). "Press Release: Lophius Biosciences Closes Financing Round and Expands Management Board. Financing Round Closed with Volume of about 4 Mio. EUR". Regensburg.
Record changed: 2017-09-29


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Lophius Biosciences GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] Made Without Love 650x80px

» top